Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team

CellaVision

195.2

 

SEK

 

-1.31 %

1,483 following

CEVI

NASDAQ Stockholm

Medical Equipment & Services

Health Care

Overview
Ownership
Investor consensus
Compare
-1.31%
+20.2%
+9.54%
-10.25%
-11.87%
-23.45%
-43.5%
-33.83%
+1,151.28%

CellaVision operates in the medical technology industry and focuses on the development and manufacture of systems for digital blood analysis. The company focuses on digital cell morphology and offers innovations for analyzers, instruments, reagents and software used in hematology laboratories. The company's products are aimed at healthcare institutions and laboratories worldwide. CellaVision was founded in 1994 and is headquartered in Lund, Sweden.

Read more
Market cap
4.66B SEK
Turnover
1.89M SEK
Revenue
723.22M
EBIT %
24.57 %
P/E
33.08
Dividend yield-%
1.28 %
Financial calendar
18/7
2025

Interim report Q2'25

6/11
2025

Interim report Q3'25

5/2
2026

Annual report '25

All
Webcasts
Press releases
ShowingAll content types
Regulatory press release5/14/2025, 6:45 AM

CellaVision AB meddelar förändring i ledningsgruppen

CellaVision
Regulatory press release5/14/2025, 6:45 AM

CellaVision AB announces change in management team

CellaVision
Regulatory press release5/6/2025, 3:00 PM

Kommuniké från årsstämma i CellaVision AB (publ)

CellaVision

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Regulatory press release5/6/2025, 3:00 PM

Bulletin from the Annual General Meeting of CellaVision AB (publ)

CellaVision
Press release5/6/2025, 9:03 AM

Redeye: Cellavision Q1 2025 - EMEA Drove Sales Growth

CellaVision
CellaVision, Audiocast with teleconference, Q1'25
Webcast4/29/2025, 9:00 AM

CellaVision, Audiocast with teleconference, Q1'25

CellaVision
Regulatory press release4/29/2025, 5:20 AM

Starkt kvartal i en dynamisk omvärld

CellaVision
Regulatory press release4/29/2025, 5:20 AM

Strong quarter in a rapidly changing environment

CellaVision
Press release4/24/2025, 12:45 PM

Modular Finance IR Consensus: CellaVision – Consensus estimates Q1 2025

CellaVision
Press release4/15/2025, 6:20 AM

Inbjudan till presentation av CellaVisions rapport för första kvartalet 2025, den 29 april kl. 11:00

CellaVision
Press release4/15/2025, 6:20 AM

Invitation to Presentation of the CellaVision Report for the First Quarter 2025 on April 29, at 11:00 CEST

CellaVision
Regulatory press release4/10/2025, 6:20 AM

CellaVision publicerar års- och hållbarhetsredovisning för 2024

CellaVision
Regulatory press release4/10/2025, 6:20 AM

CellaVision publishes its 2024 Annual and Sustainability Report

CellaVision
Regulatory press release4/2/2025, 6:00 AM

KALLELSE TILL ÅRSSTÄMMA i CELLAVISION AB (PUBL)

CellaVision
Regulatory press release4/2/2025, 6:00 AM

NOTICE OF ANNUAL GENERAL MEETING IN CELLAVISION AB (publ)

CellaVision
CellaVision, Audiocast with teleconference, Q4'24
Webcast2/6/2025, 10:00 AM

CellaVision, Audiocast with teleconference, Q4'24

CellaVision
Regulatory press release2/6/2025, 6:20 AM

Varierande marknadsutveckling Rekordförsäljning i APAC

CellaVision
Regulatory press release2/6/2025, 6:20 AM

Mixed Regional Performance Sales Peak in APAC

CellaVision
Press release2/3/2025, 1:00 PM

Modular Finance IR Consensus: CellaVision – Consensus estimates Q4 2024

CellaVision
Press release1/24/2025, 7:20 AM

Inbjudan till presentation av CellaVisions bokslutskommuniké för 2024, den 6 februari kl. 11:00

CellaVision
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team